ArticleAnnals of surgical oncology2025

Outcomes After Neoadjuvant Targeted Therapy in Patients with ALK or ROS1 Rearrangement Locally Advanced Non-small Cell Lung Cancer.

Zhao An et al.PubMed ↗Publisher ↗

No numbers read from the abstract.